Male Urogenital Diseases

160 trials 69 recruiting

Filter these 160 trials by phase, country and sponsor.

Open in Search →

BeDry Recruiting

2023-510187-13-00 Daytime urinary incontinence and overactive bladder 5 2024-06-27
Ebastine in combination with docetaxel or as a treatment for metastatic castration-resistant prostate cancer Recruiting

2024-518035-11-01 metastatic castration-resistant prostate cancer (mCRPC) 4 2024-06-02
Fractionated stereotactic radiotherapy plus second-generation antiandrogen for oligometastatic patients with castration-resistant prostate c… Recruiting

2023-505024-62-01 Oligometastatic patients with castration-resistant pro 4 2024-05-16
SMILe: Spinal Morphine or Intravenous Lidocaine in robot-assisted upper urologic surgery Recruiting

2023-505941-21-00 Renal or ureter malignancy; Renal or ureter benign tumo 5 2024-04-09
Efficacy of 7 days versus 14 days of antibiotic therapy for acute pyelonephritis in kidney transplant recipients Recruiting

2024-513328-40-00 Pyelonephritis 6 2024-03-25
A Randomised study comparing Lutetium-177 versus Apalutamide/Enzalutamide/Abiraterone, in metastatic Hormon Sensitive Prostate Cancer in PSM… Recruiting

2022-500570-33-00 Prostate cancer 5 2024-02-28
A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination with Darolutamide in Metastatic Cas… Recruiting

2023-505898-32-00 Metastasic Castration-Resistant Prostate Cancer (mCRPC) 9 2024-02-28
THE EFFECT OF ABIRATERONE ON THE METABOLISM OF OXYCODONE (ENABLE study) Recruiting

2023-505705-17-00 Males aged  18 years with prostate cancer treated with 6 2024-02-23
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
PEHAB II Recruiting

2023-507466-40-00 Prostate cancer 6 2024-01-12
Evaluation of the impact of metastasis-directed therapy in patients with castration-refractory prostate cancer and a maximum of 5 progressiv… Recruiting

2022-502254-13-00 Oligoprogressive metastatic castration-refractory prost 5 2023-12-18
Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosis Recruiting

2022-502426-41-00 Thromboprophylaxis in good and intermediate prognosis a 5 2023-10-17
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting

2024-513562-19-00 End-Stage Kidney Disease 5 2023-08-30
A phase II randomized trial of Lu-PSMA and Stereotactic Radiotherapy versus Radiotherapy alone for oligometastatic prostate cancer (LUST) Recruiting

2024-519347-15-00 Oligometastatic prostate carcinoma 4 2023-06-27
A prospective program aiming at improving outcome for young adults with poor-prognosis non seminomatous germ-cell tumors (VAPOR (GETUG T06)) Recruiting

2023-505040-19-00 Non-seminomatous germ-cell tumors (including testis, re 4 2023-04-11
Measuring Oncological Value of Exercise and Statin (MOVES) Recruiting

2024-515109-24-00 Metastatic breast, ovarian, prostate and kidney cancer 5 2023-03-31
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 Uncontrolled Hypertension IN patients with moderate to 5 2023-03-28
Clinical trial of androgen deprivation therapy combined with salvage radiotherapy when treating prostate cancer that has suffered recurrence… Recruiting

2024-517666-41-00 Prostate Cancer 5 2023-03-13
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN). Recruiting

2023-507233-19-00 Treatment of IgAN 10 2023-02-16
Prostate medication, metabolism and gut microbiota, PROMED. Recruiting

2022-500618-24-00 prostate cancer, benign prostate hyperplasia 6 2022-12-01
Phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC 1 in men with biochemical… Recruiting

2024-511430-12-00 Prostate cancer recurrent 1 2022-11-11
99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging, PROSTAM… Recruiting

2024-516083-28-00 Prostate cancer 10 2022-06-01
Metastasis-directed therapy, whether or not in combination with hormone therapy, in patients with prostate cancer recurrence after initial t… Recruiting

2022-502373-42-00 Oligorecurrent hormone-sensitive prostate cancer patien 5 2022-04-25
PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF EARLY OXYBUTININ TREATMENT FOR BOYS WITH POSTERIOR URETHRAL VALVES - PRETIPUV - Recruiting

2024-515844-22-00 urethral posterior valve 4 2020-09-10